ZIM
FBIO icon

Zacks Investment Management’s Fortress Biotech FBIO Stock Holding History

Zacks Investment Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-5,583
Closed -$166K – 687
2014
Q1 		$166K Buy
+5,583
New +$218K 0.01% 648

Other funds holding FBIO

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Zacks Investment Management's FBIO Position: Q2 2014 in Review

Zacks Investment Management sold out of Fortress Biotech (FBIO) in Q2 2014, closing a stake of 5,583 shares — an estimated $166K sold.

Zacks Investment Management first reported a position in FBIO in Q1 2014 and held it in 1 quarter. The position peaked at $166K in Q1 2014. 48 funds tracked by Wall St. Rank hold FBIO as of Q2 2014.

  • Zacks Investment Management reported no remaining Fortress Biotech position as of Q2 2014 after selling out during the quarter.
  • Zacks Investment Management sold 5,583 Fortress Biotech shares in Q2 2014, an estimated $166K.
  • Zacks Investment Management first reported a position in Fortress Biotech in Q1 2014 and held it in 1 quarter.
  • Zacks Investment Management's Fortress Biotech position peaked at $166K in Q1 2014.
  • 48 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2014.

Based on Zacks Investment Management's 13F filing for Q2 2014, filed 12 Aug 2014.